Literature DB >> 23879271

Value of electro-vectorcardiogram in hypertrophic cardiomyopathy.

Andrés Ricardo Pérez-Riera1, Augusto Armando de Lucca, Raimundo Barbosa-Barros, Frank G Yanowitz, Silvia Fortunato de Cano, Manuel Nicolás Cano, Antônio Carlos Palandri-Chagas.   

Abstract

The electrocardiogram is an important tool for the initial diagnostic suspicion of hypertrophic cardiomyopathy in any of its forms, both in symptomatic and in asymptomatic patients because it is altered in more than 90 percent of the cases. Electrocardiographic anomalies are more common in patients carriers of manifest hypertrophic cardiomyopathy and the electrocardiogram alterations are earlier and more sensitive than the increase in left ventricular wall thickness detected by the echocardiogram. Nevertheless, despite being the leading cause of sudden death among young competitive athletes there is no consensus over the need to include the method in the pre-participation screening. In apical hypertrophic cardiomyopathy the electrocardiographic hallmarks are the giant negative T waves in anterior precordial leads. In the vectorcardiogram, the QRS loop is located predominantly in the left anterior quadrant and T loop in the opposite right posterior quadrant, which justifies the deeply negative T waves recorded. The method allows estimating the left ventricular mass because it relates to the maximal spatial vector voltage of the left ventricle in the QRS loop. The recording on electrocardiogram or Holter monitoring of nonsustained monomorphic ventricular tachycardia in patients with syncope, recurrent syncope in young patient, hypotension induced by strain, bradyarrhythmia, or concealed conduction are markers of poor prognosis. The presence of rare sustained ventricular tachycardia is observed in mid-septal obstructive HCM with apical aneurysm. The presence of complete right bundle branch block pattern is frequent after the percutaneous treatment and complete left bundle branch block is the rule after myectomy. ©2013, Wiley Periodicals, Inc.

Entities:  

Keywords:  electrocardiogram; hypertrophic cardiomyopathy; vectorcardiogram

Mesh:

Year:  2013        PMID: 23879271      PMCID: PMC6932007          DOI: 10.1111/anec.12067

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  52 in total

1.  P-WAVE ANALYSIS IN VALVULAR HEART DISEASE.

Authors:  J J MORRIS; E H ESTES; R E WHALEN; H K THOMPSON; H D MCINTOSH
Journal:  Circulation       Date:  1964-02       Impact factor: 29.690

2.  [Electrocardiogram in ventricular strain].

Authors:  J R MONROY; E CABRERA
Journal:  Arch Inst Cardiol Mex       Date:  1952-06

3.  Apical aneurysm in a patient with apical hypertrophic cardiomyopathy.

Authors:  Constantin B Marcu; Ajoy Kapoor; Thomas J Donohue
Journal:  Conn Med       Date:  2006-05

4.  Cardiac arrest and ventricular tachycardia in Japanese-type apical hypertrophic cardiomyopathy.

Authors:  Denio Ridjab; Matthias Koch; Markus Zabel; Heinz-Peter Schultheiss; Andreas J Morguet
Journal:  Cardiology       Date:  2006-06-27       Impact factor: 1.869

5.  Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program.

Authors:  Domenico Corrado; Cristina Basso; Andrea Pavei; Pierantonio Michieli; Maurizio Schiavon; Gaetano Thiene
Journal:  JAMA       Date:  2006-10-04       Impact factor: 56.272

6.  Predictors of complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy and the timing of pacemaker implantation.

Authors:  Seifeddin S El-Jack; Marwan Nasif; James W Blake; Simon R Dixon; Cindy L Grines; William W O'Neill
Journal:  J Interv Cardiol       Date:  2007-02       Impact factor: 2.279

7.  Electrocardiographic changes after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.

Authors:  J Kazmierczak; Z Kornacewicz-Jach; M Kisly; R Gil; A Wojtarowicz
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

8.  Screening for hypertrophic cardiomyopathy in young athletes.

Authors:  D Corrado; C Basso; M Schiavon; G Thiene
Journal:  N Engl J Med       Date:  1998-08-06       Impact factor: 91.245

9.  Sudden unexpected death in children and adolescents.

Authors:  D J Driscoll; W D Edwards
Journal:  J Am Coll Cardiol       Date:  1985-06       Impact factor: 24.094

10.  Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients.

Authors:  Lorenzo Monserrat; Perry M Elliott; Juan R Gimeno; Sanjay Sharma; Manuel Penas-Lado; William J McKenna
Journal:  J Am Coll Cardiol       Date:  2003-09-03       Impact factor: 24.094

View more
  5 in total

1.  Rare Association: Chagas' Disease and Hypertrophic Cardiomyopathy.

Authors:  Carlos Alberto Pastore; Nelson Samesima; Horácio Gomes Pereira Filho; Leonardo Paschoal Camacho Varoni; Carlos Eduardo Rochitte; Marcelo Luiz Vieira; Luiz Francisco Rodrigues de Ávila; Rodrigo de Jesus Louzeiro Melo; Alexandre da Costa Pereira; Julia Daheer; Carlos Henrique del Carlo
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-11-04       Impact factor: 1.468

Review 2.  The 12-lead electrocardiogram and risk of sudden death: current utility and future prospects.

Authors:  Kumar Narayanan; Sumeet S Chugh
Journal:  Europace       Date:  2015-10       Impact factor: 5.214

Review 3.  The tetrafascicular nature of the intraventricular conduction system.

Authors:  Andrés R Pérez-Riera; Raimundo Barbosa-Barros; Rodrigo Daminello-Raimundo; Luiz C de Abreu; Kjell Nikus
Journal:  Clin Cardiol       Date:  2018-12-13       Impact factor: 2.882

Review 4.  Left bundle branch block: Epidemiology, etiology, anatomic features, electrovectorcardiography, and classification proposal.

Authors:  Andrés R Pérez-Riera; Raimundo Barbosa-Barros; Marianne P C de Rezende Barbosa; Rodrigo Daminello-Raimundo; Luiz C de Abreu; Kjell Nikus
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-06-22       Impact factor: 1.468

Review 5.  Hypertrophic cardiomyopathy: Can the noninvasive diagnostic testing identify high risk patients?

Authors:  Li Zhang; Obinna Mmagu; Liwen Liu; Dayuan Li; Yuxin Fan; Adrian Baranchuk; Peter R Kowey
Journal:  World J Cardiol       Date:  2014-08-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.